PKM and hepatocellular carcinoma: Consistent with these points, our study indicated that the introduction of miR-122 inhibited the expression of PKM2 and subsequent ATP production, lack of which facilitated the doxorubicin-induced apoptosis in DOX-resistant HCC cells.